New cancer clinical trial: Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

Published on: April 24, 2018 at 12:00PM
Condition:   Metastatic Breast Cancer
Intervention:   Drug: Fluoroestradiol (18F)
Sponsor:   Zhimin Shao
Recruiting
https://ift.tt/2vEQWcQ